Department of Anthropology/Institute for Social Science Research, University of Alabama, 24b Ten Hoor Hall, Tuscaloosa, AL, 35487, USA.
Institute for Health and Aging, University of California, San Francisco, 490 Illinois St, Box 0646, San Francisco, CA, 94158, USA.
J Assist Reprod Genet. 2023 Jun;40(6):1291-1304. doi: 10.1007/s10815-023-02855-3. Epub 2023 Jun 22.
To evaluate self-reported survey data provided by US oocyte donors on their experiences with ovarian hyperstimulation syndrome and possible correlations between OHSS severity and number of oocytes retrieved, trigger type, and prior OHSS history.
An 85-question retrospective survey was administered online. Survey questions included demographic information, reasons for donating, immediate per-cycle experiences and outcomes, perceptions of informed consent, and perceived impact of donation on long-term health. Quantitative Data for this study was collected between February 2019 and September 2020 via Qualtrics (January 2019), an online survey platform. Follow-up interviews were also conducted. Participants were recruited via fertility clinics, egg donation agencies, and online forum. The research was approved by the University of California, San Francisco Institutional Review Board (#14-14765).
Of 420 initiated US oocyte donor online surveys, 289 (68%) respondents provided detailed information on per cycle experiences with ovarian hyperstimulation syndrome, number of oocytes retrieved, and trigger type over a total of 801 cycles. On cycles where donors reported receiving GnRH agonist triggers (n = 337), they reported milder OHSS compared to cycles with hCG or dual triggers. Among donors undergoing multiple retrieval cycles, the severity of OHSS in second cycles was strongly associated with OHSS severity in first cycles.
Self-reported OHSS in oocyte donors is lower in GnRH antagonist stimulation protocols combined with GnRHa trigger and in cycles where donors reported fewer than 30 oocytes retrieved. Donors who reported severe OHSS on a prior cycle were significantly more likely to experience severe OHSS on a subsequent cycle.
评估美国卵子供体提供的关于其卵巢过度刺激综合征(OHSS)经历的自我报告调查数据,以及 OHSS 严重程度与获卵数、触发类型和既往 OHSS 史之间的可能相关性。
采用在线方式进行了 85 个问题的回顾性调查。调查问题包括人口统计学信息、捐赠原因、每个周期的即时经历和结果、对知情同意的看法,以及对捐赠对长期健康影响的看法。本研究的定量数据于 2019 年 2 月至 2020 年 9 月通过 Qualtrics(2019 年 1 月)收集,这是一个在线调查平台。还进行了后续访谈。参与者是通过生育诊所、卵子捐赠机构和在线论坛招募的。该研究得到了加利福尼亚大学旧金山分校机构审查委员会的批准(#14-14765)。
在 420 名开始接受美国卵子供体在线调查的人中,289 名(68%)受访者在总共 801 个周期中提供了有关卵巢过度刺激综合征的每个周期经历、获卵数和触发类型的详细信息。在接受 GnRH 激动剂触发的周期(n=337)中,与接受 hCG 或双重触发的周期相比,供体报告的 OHSS 较轻。在接受多次取卵周期的供体中,第二周期 OHSS 的严重程度与第一周期 OHSS 的严重程度密切相关。
在 GnRH 拮抗剂刺激方案联合 GnRHa 触发以及供体报告获卵数少于 30 个的周期中,卵子供体的自我报告 OHSS 较低。在前一个周期报告严重 OHSS 的供体在后一个周期中发生严重 OHSS 的可能性显著增加。